Drugmakers Eye $23 Billion Biotech Argenx Ahead of Key Data

US FTC sues to block Amgen's $27.8 billion deal for Horizon Therapeutics

FTC Commissioners yet to meet on Amgen-Horizon deal - CNBC

FTC to block Amgen's deal to acquire Horizon Therapeutics - source

FTC to Sue to Block Amgen’s Takeover of Horizon Therapeutics